{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:47:11Z","timestamp":1765486031545},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ajg.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T16:50:05Z","timestamp":1466959805000},"page":"78-83","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection"],"prefix":"10.1016","volume":"17","author":[{"given":"Ayman","family":"Yosry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen A.","family":"Alem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha","family":"Asem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2016.05.002_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.ajg.2016.05.002_b0010","unstructured":"EASL recommendations on treatment of hepatitis C 2014;1:22."},{"key":"10.1016\/j.ajg.2016.05.002_b0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"Management of hepatitis C virus infection","volume":"55","author":"EASL Clinical Practice Guidelines","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2016.05.002_b0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/DHPS.S43304","article-title":"Benefit-risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir","volume":"6","author":"Gaetano","year":"2014","journal-title":"Drug Health Patient Saf"},{"key":"10.1016\/j.ajg.2016.05.002_b0025","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2016.05.002_b0030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2016.05.002_b0035","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis inpatients with HIV\/HCV co-infection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2016.05.002_b0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00365520701514461","article-title":"A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection","volume":"43","author":"Westin","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ajg.2016.05.002_b0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"For the Metavir cooperation study group: an algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatol"},{"key":"10.1016\/j.ajg.2016.05.002_b0050","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"issue":"6 Suppl. 1","key":"10.1016\/j.ajg.2016.05.002_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0399-8320(08)73994-0","article-title":"Transient elastography (FibroScan)","volume":"32","author":"De ledinghen","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.ajg.2016.05.002_b0060","series-title":"Egypt demographic and health survey 2008","author":"El-Zanaty","year":"2009"},{"issue":"3","key":"10.1016\/j.ajg.2016.05.002_b0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1478-3231.2006.01430.x","article-title":"Progression to cirrhosis in hepatitis C patients: an age-dependent process","volume":"27","author":"Pradat","year":"2007","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.ajg.2016.05.002_b0070","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ajg.2016.05.002_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jvh.12285","article-title":"Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt","volume":"22","author":"Bonnard","year":"2015","journal-title":"J Viral Hepat"},{"issue":"Suppl. 1","key":"10.1016\/j.ajg.2016.05.002_b0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2893.2011.01518.x","article-title":"How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?","volume":"19","author":"Sebastiani","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ajg.2016.05.002_b0085","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10096-011-1513-6","article-title":"Comparison of noninvasive fibrosis markers and classical liver biopsy in chronic hepatitis C","volume":"31","author":"Usluer","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.ajg.2016.05.002_b0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/hepr.12385","article-title":"Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns\u2019 index in chronic hepatitis C virus","volume":"45","author":"Alboraie","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ajg.2016.05.002_b0095","first-page":"218","article-title":"Non-invasive assessment of liver fibrosis","volume":"25","author":"Papastergiou","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.ajg.2016.05.002_b0100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/00365520510015674","article-title":"Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers","volume":"40","author":"Islam","year":"2005","journal-title":"Scan J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ajg.2016.05.002_b0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4318\/tjg.2012.0358","article-title":"Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients","volume":"23","author":"Mahmut","year":"2012","journal-title":"Turk J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ajg.2016.05.002_b0110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2036.2003.01463.x","article-title":"Review article: indicators and predictors of response to antiviral therapy in chronic HCV","volume":"17","author":"Lee","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2016.05.002_b0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/00042737-200409000-00013","article-title":"Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression","volume":"16","author":"Zechini","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2016.05.002_b0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ajg.2016.05.002_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0256-4947.51810","article-title":"Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects","volume":"29","author":"Abdo","year":"2009","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.ajg.2016.05.002_b0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4236\/aid.2013.32012","article-title":"Predictors of complete early virological response to pegylated interferon and ribavirin in Egyptian patients with chronic hepatitis C genotype 4","volume":"3","author":"Esmat","year":"2013","journal-title":"Adv Infect Dis"},{"key":"10.1016\/j.ajg.2016.05.002_b0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajg.2013.08.005","article-title":"Hepatic fibrosis and serum alphafetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment","volume":"14","author":"El Raziky","year":"2013","journal-title":"Arab J Gastroenterol"},{"issue":"10","key":"10.1016\/j.ajg.2016.05.002_b0140","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.3748\/wjg.v21.i10.3013","article-title":"Stiffness prognostic value in patients with hepatitis C virus treated with triple or dual antiviral therapy: a prospective pilot study","volume":"21","author":"Stasi","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.ajg.2016.05.002_b0145","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4254\/wjh.v7.i12.1617","article-title":"Predictive factors associated with hepatitis C antiviral therapy response","volume":"7","author":"Cavalcante","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ajg.2016.05.002_b0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.mcg.0000225661.23179.6d","article-title":"Liver biopsy and non-invasive alternatives in relationship to the duration of antiviral treatment for hepatitis C. Letter to Editor","volume":"42","author":"Colletta","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.ajg.2016.05.002_b0155","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.3748\/wjg.v21.i10.3013","article-title":"Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: a prospective pilot study","volume":"21","author":"Stasi","year":"2015","journal-title":"World J Gastroentrol"},{"key":"10.1016\/j.ajg.2016.05.002_b0160","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.dld.2013.03.023","article-title":"Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C","volume":"45","author":"Stasi","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"Suppl. S3","key":"10.1016\/j.ajg.2016.05.002_b0165","first-page":"19","article-title":"Non-invasive liver fibrosis scores: do they also predict antiviral treatment response, decompensation, hepatocellular carcinoma and significant liver related adverse events? poster abstract","volume":"22","author":"Thandassery","year":"2015","journal-title":"J Viral Hepatitis"},{"issue":"39","key":"10.1016\/j.ajg.2016.05.002_b0170","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.3748\/wjg.15.4923","article-title":"APRI as a predictor of early viral response in chronic hepatitis C patients","volume":"15","author":"Mata-Marin","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ajg.2016.05.002_b0175","first-page":"375","article-title":"Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C","volume":"21","author":"Crisan","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"issue":"2","key":"10.1016\/j.ajg.2016.05.002_b0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3851\/IMP2805","article-title":"Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferonand ribavirin for chronic hepatitis C","volume":"20","author":"Ogawa","year":"2015","journal-title":"Antivir Ther"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197916300272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197916300272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T06:48:10Z","timestamp":1568098090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197916300272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1687197916300272"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2016.05.002","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Arab Journal of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}